We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.005 | -0.11% | 4.75 | 4.52 | 4.74 | 4.75 | 4.75 | 4.75 | 33,333 | 08:00:18 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.53 | 9.58M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 13/8/2020 19:29 | Strongbuy - I totally agree, £6bn really doesn't seem much for a treatment for a global pandemic. Or even £10bn come to that. Trump has raised $100bn to get re-elected: how much do you think he would tell a loyal pharma company CEO to pay to buy SNG so he could then brag about America having a 'cure'?As an American senator once said: a billion here and a billion there and pretty soon you're talking real money... | sloppyjoe2 | |
| 13/8/2020 19:25 | This treatment is much bigger than just for COVID!! Who knows how high the share price could go | blakieboy7 | |
| 13/8/2020 19:18 | Sloppy, if anyone followed me years ago they will see I was right on Taylor Wimpy at 5p , Greatland at 0.004p, and Vodafone at 62p etc, I really do think if my research is correct and the government advisors agree with the data then this could go to some very serious heights as there is a limited amount of stock available and this could be a significant cash cow delivering significant dividends for many years to come £40-£50 would look cheap in the near future, wait and see £6bn is nothing really for what this could be worth, it’s a steal at today’s prices 😉🚀&# | strongbuy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
